Sanjay Ramakrishnan
sanjayresp.bsky.social
Sanjay Ramakrishnan
@sanjayresp.bsky.social
Academic respiratory physician and clinical researcher. Asthma & COPD. Perth, Western Australia
Reposted by Sanjay Ramakrishnan
🚨 𝐌𝐚𝐣𝐨𝐫 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐢𝐧 𝐚𝐬𝐭𝐡𝐦𝐚 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭!
💉 Benralizumab reduces the need for additional care during attacks by 30%, outperforming steroids.
📝 @btsrespiratory.bsky.social @sanjayresp.bsky.social
@thelancet.bsky.social

theconversation.com/first-new-tr...
#AsthmaResearch #COPD
First new treatment for asthma and COPD in half a century – new study
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets.
theconversation.com
December 13, 2024 at 5:41 PM
Reposted by Sanjay Ramakrishnan
ABRA study covered by the media today, getting the attention it deserves 🤩

Congratulations @sanjayresp.bsky.social !
Doctors hail first breakthrough in asthma and COPD treatment in 50 years | Asthma | The Guardian
Results of trial of benralizumab injection could be ‘gamechanger’ for millions of people around the world
amp.theguardian.com
November 28, 2024 at 2:52 PM
Reposted by Sanjay Ramakrishnan
Sanjay Ramakrishnan is here! 🤩 @sanjayresp.bsky.social

Definitely one to follow (and add to lists) if you’re into COPD and asthma 🫁 🙌 #ABRAstudy

#MedSky
#LungSky
#PulmSky
#lungresearch
#BTSWinter2024

www.thelancet.com/journals/lan...
Sanjay Ramakrishnan (@sanjayresp.bsky.social)
Academic respiratory physician and clinical researcher. Asthma & COPD. Perth, Western Australia
sanjayresp.bsky.social
November 28, 2024 at 9:49 AM